Shaw Capital Working Management Tips: Merck Capital Ventures Joins $15.7M Series D for HTG
HTG, Inc., provider of molecular technology solutions, today announced the closing of a Series D financing round led by new investor Novo A/S. Fletcher Spaght Ventures (FSV) also a new investor, joined the round along with existing investors Merck Capital Ventures, Solstice Capital and Valley Ventures.
View full press release